LGALS3 and cancer: Galectin-3, a member of the galectin family (galectins 1–15), has both anti- and pro-apoptotic effects, expressed in the nucleus and cytoplasm [23], [24], affects Ras-signaling in cancers[25] and nuclear localization may induce resistance to treatment [26], [27].